Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?
Marie‐Thérèse Armentero, Silvia Cerri, Fabio Blandini
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
Preston Ge, Valina L. Dawson, Ted M. Dawson
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 372
Neurosteroids as regulators of neuroinflammation
Canelif Yılmaz, Kanelina Karali, Georgia Fodelianaki, et al.
Frontiers in Neuroendocrinology (2019) Vol. 55, pp. 100788-100788
Open Access | Times Cited: 180
Advancement in the modelling and therapeutics of Parkinson’s disease
Sachchida Nand, Payal Singh
Journal of Chemical Neuroanatomy (2020) Vol. 104, pp. 101752-101752
Closed Access | Times Cited: 163
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Bruna Araújo, Rita Caridade-Silva, Carla Guedes, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2908-2908
Open Access | Times Cited: 83
Neuraxial Cytokines in Pain States
Gilson Gonçalves dos Santos, Lauriane Delay, Tony L. Yaksh, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 126
Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links
Ho‐Su Lee, Evy Lobbestael, Séverine Vermeire, et al.
Gut (2020), pp. gutjnl-322429
Open Access | Times Cited: 125
Microbiota metabolites modulate the T helper 17 to regulatory T cell (Th17/Treg) imbalance promoting resilience to stress-induced anxiety- and depressive-like behaviors
Susan Westfall, Francesca Caracci, Danyue Zhao, et al.
Brain Behavior and Immunity (2020) Vol. 91, pp. 350-368
Open Access | Times Cited: 110
Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk
Austin P. Passaro, Abraham L. Lebos, Yao Yao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 76
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease
Micol Avenali, Fabio Blandini, Silvia Cerri
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 75
Cellular and molecular pathophysiology in the progression of Parkinson’s disease
Vandana Zaman, Donald C. Shields, Ramsha Shams, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 5, pp. 815-827
Open Access | Times Cited: 72
Peripheral Immune Profile and Neutrophil‐to‐Lymphocyte Ratio in Parkinson's Disease
Laura Muñoz‐Delgado, Daniel Macías‐García, Silvia Jesús, et al.
Movement Disorders (2021) Vol. 36, Iss. 10, pp. 2426-2430
Closed Access | Times Cited: 61
Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice
Savannah M. Rocha, Collin M. Bantle, Tawfik Aboellail, et al.
Neurobiology of Disease (2022) Vol. 167, pp. 105685-105685
Open Access | Times Cited: 45
The systemic immune response in Parkinson’s disease: focus on the peripheral immune component
Johanne Lauritsen, Marina Romero‐Ramos
Trends in Neurosciences (2023) Vol. 46, Iss. 10, pp. 863-878
Open Access | Times Cited: 29
Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
Laura Muñoz‐Delgado, Daniel Macías‐García, María Teresa Periñán, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease
Laura Muñoz‐Delgado, Miguel A. Labrador‐Espinosa, Daniel Macías‐García, et al.
Movement Disorders (2023) Vol. 38, Iss. 5, pp. 755-763
Open Access | Times Cited: 22
The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-high-density-lipoprotein ratio are correlated with the severity of Parkinson’s disease
Fangyi Li, Guomei Weng, Hang Zhou, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 10
Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation
Diego Cabezudo, Veerle Baekelandt, Evy Lobbestael
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 61
New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
Marina Lorente Picón, Ariadna Laguna
Biomolecules (2021) Vol. 11, Iss. 3, pp. 433-433
Open Access | Times Cited: 51
Parkinson's disease and vitamins: a focus on vitamin B12
Arwa Rekik, Carlo Santoro, Karolina Popławska-Domaszewicz, et al.
Journal of Neural Transmission (2024)
Open Access | Times Cited: 6
Can the gut be the missing piece in uncovering PD pathogenesis?
Guillaume Chapelet, Laurène Leclair‐Visonneau, Thomas Clairembault, et al.
Parkinsonism & Related Disorders (2018) Vol. 59, pp. 26-31
Open Access | Times Cited: 52
Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease
Gagandeep Kaur, Tapan Behl, Simona Bungău, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 2, pp. 233-247
Open Access | Times Cited: 46
Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson’s disease
Congcong Sun, Zhenxiang Zhao, Wenfei Yu, et al.
Annals of Translational Medicine (2019) Vol. 7, Iss. 22, pp. 637-637
Open Access | Times Cited: 44
Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System
Daniela C. Ivan, Sabrina Walthert, Kristina Berve, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 36
Role and Mechanism of Vitamin A Metabolism in the Pathophysiology of Parkinson’s Disease
Anaïs Marie, Morgane Darricau, Katia Touyarot, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 3, pp. 949-970
Open Access | Times Cited: 35
Dopamine receptor D2 on CD4+ T cells is protective against neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease
Zhan Liu, Xiao-Run Zhai, Zhong-Shuai Du, et al.
Brain Behavior and Immunity (2021) Vol. 98, pp. 110-121
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top